27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
China's Tsinghua Unigroup chairman, Zhao Weiguo, has reportedly traveled to the United States to meet with Micron Technology (NASDAQ: MU) board members, to discuss a potential takeover bid, according to souces as reported by Reuters. Mr. Zhao is also attempting to deal with US national security concerns by meeting with experts in the field. Senator Schumer has called for the deal to be blocked, as Micron chips are used in U.S. weapons systems.Micron rejected a $23 billion offer in July from Tsinghua Unigroup.Representatives from Micron and Tsinghua did not immediately respond to requests for comment.Micron closed at $15.96 on Friday, a gain of almost 2%. Mylan Shareholders Approve Perrigo Proposed AcquisitionThe Shareholder Approval:
Mylan N.V. (NYSE: MYL) announced Friday, that its shareholders approved the co's proposed acquisition of Perrigo Company plc (NYSE: PRGO). Two-thirds of the votes cast were in favor of the deal.Perrigo responded, stating they were confident that most shareholders believe Mylan's unsolicited offer substantially undervalues Perrigo and would reject the proposal.Perrigo 1.5% Friday, closing at $185.42. Mylan fell 2%, closing at $50.37.Investors May Slash $77/Share Qihoo 360 BidThe Rumor:
The group of investors who bid $77.00 per share for Qihoo 360 Technology in June, may cut its offer following the recent selloff in the Chinese stock market, according to sources, as reported by the Wall Street Journal. Qihoo 360 announced receipt of the preliminary non-binding $9 billion offer on Jun 17.Qihoo 360 said in June it had received a buyout offer from chief executive and some investors for $77.00 in cash per ADSQihoo 360 shares closed at $52.66 Friday, a up 2.5%. Shares had traded down 2.5% in the premarket.Ariad Said to be in Takeover Talks With BaxaltaThe Rumor:
Shares of Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) soared higher Friday, on a report from the Boston Globe that the biotech company was in talks to sell itself to Baxlata, Inc. (NYSE: BXLT), according to sources. An acqusition of Ariad and its leukemia drug Iclusing, is seen as an attempt for Baxalta to fight off a takeover by Shire PLC (NASDAQ: SHPG). Baxalta rejected a $45.23 per share all-stock offer from Shire on August 4, saying the proposal was "not a basis for further discussions."Aria shares closed at $9.89 Friday, a gain of more than 41% on 10 times average volume.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!